Hollie K. Foust, the General Counsel and Corporate Secretary of CONMED Corp, has reported significant stock transactions in a recent SEC filing. On November 4, 2026, Foust acquired 4,000 shares of CONMED's common stock, alongside 4,000 restricted stock units (RSUs). This move indicates a notable increase in her ownership stake and reflects her confidence in the company's future performance.

CONMED Corp, a leader in the electromedical and electrotherapeutic apparatus industry, is known for its innovative medical devices. The company, incorporated in Delaware, has been actively involved in developing products that enhance surgical procedures and patient care. As of the latest filing, CONMED's stock is traded under the symbol CNMD.

The filing reveals that Foust's transactions included acquiring 4,000 shares of common stock at no cost and 4,000 RSUs, which are contingent rights to receive shares of common stock. Following these transactions, Foust now owns a total of 6,886 shares of CONMED's common stock. The RSUs are subject to a two-year vesting period, with 50% vesting after the first year and the remaining 50% after the second year.

According to the SEC filing (accession number 0000816956-26-000115), Foust's transactions were categorized as direct ownership, indicating her personal investment in the company. The details of the transactions are as follows:

“On November 4, 2026, Foust acquired 4,000 shares of common stock and 4,000 RSUs.”

This update may have implications for CONMED's stakeholders, including investors and employees. Foust's increased ownership could signal her strong belief in the company's direction and growth potential, potentially influencing investor sentiment and employee morale.

The filing does not specify what actions will follow these transactions. However, it underscores the ongoing commitment of CONMED's leadership to the company's success in the competitive electromedical industry.